Literature DB >> 23112151

DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs.

Michelle Badura1, Steve Braunstein, Jiri Zavadil, Robert J Schneider.   

Abstract

The cellular response to DNA damage is mediated through multiple pathways that regulate and coordinate DNA repair, cell cycle arrest, and cell death. We show that the DNA damage response (DDR) induced by ionizing radiation (IR) is coordinated in breast cancer cells by selective mRNA translation mediated by high levels of translation initiation factor eIF4G1 (eukaryotic initiation factor 4γ1). Increased expression of eIF4G1, common in breast cancers, was found to selectively increase translation of mRNAs involved in cell survival and the DDR, preventing autophagy and apoptosis [Survivin, hypoxia inducible factor 1α (HIF1α), X-linked inhibitor of apoptosis (XIAP)], promoting cell cycle arrest [growth arrest and DNA damage protein 45a (GADD45a), protein 53 (p53), ATR-interacting protein (ATRIP), Check point kinase 1 (Chk1)] and DNA repair [p53 binding protein 1 (53BP1), breast cancer associated proteins 1, 2 (BRCA1/2), Poly-ADP ribose polymerase (PARP), replication factor c2-5 (Rfc2-5), ataxia telangiectasia mutated gene 1 (ATM), meiotic recombination protein 11 (MRE-11), and others]. Reduced expression of eIF4G1, but not its homolog eIF4G2, greatly sensitizes cells to DNA damage by IR, induces cell death by both apoptosis and autophagy, and significantly delays resolution of DNA damage foci with little reduction of overall protein synthesis. Although some mRNAs selectively translated by higher levels of eIF4G1 were found to use internal ribosome entry site (IRES)-mediated alternate translation, most do not. The latter group shows significantly reduced dependence on eIF4E for translation, facilitated by an enhanced requirement for eIF4G1. Increased expression of eIF4G1 therefore promotes specialized translation of survival, growth arrest, and DDR mRNAs that are important in cell survival and DNA repair following genotoxic DNA damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23112151      PMCID: PMC3503184          DOI: 10.1073/pnas.1203853109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  GammaH2AX and its role in DNA double-strand break repair.

Authors:  Jeffrey Fillingham; Michael-Christopher Keogh; Nevan J Krogan
Journal:  Biochem Cell Biol       Date:  2006-08       Impact factor: 3.626

2.  Incorporation of an internal ribosome entry site-dependent mechanism in arsenic-induced GADD45 alpha expression.

Authors:  Qingshan Chang; Deepak Bhatia; Yadong Zhang; Terry Meighan; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

3.  Translational control of meiotic cell cycle progression and spermatid differentiation in male germ cells by a novel eIF4G homolog.

Authors:  Catherine C Baker; Margaret T Fuller
Journal:  Development       Date:  2007-07-04       Impact factor: 6.868

4.  Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer.

Authors:  Jeffrey M Albert; Kwang Woon Kim; Carolyn Cao; Bo Lu
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

5.  Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells.

Authors:  Eileen Connolly; Steve Braunstein; Silvia Formenti; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

6.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells.

Authors:  Carolyn Cao; Ty Subhawong; Jeffrey M Albert; Kwang Woon Kim; Ling Geng; Konjeti R Sekhar; Young Jin Gi; Bo Lu
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

7.  Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.

Authors:  Yuri V Svitkin; Barbara Herdy; Mauro Costa-Mattioli; Anne-Claude Gingras; Brian Raught; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

8.  MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle.

Authors:  Shou-Ih Hu; Mark Katz; Sherry Chin; Xiaoqing Qi; Joseph Cruz; Chikwendu Ibebunjo; Shanchuan Zhao; Amy Chen; David J Glass
Journal:  Sci Signal       Date:  2012-02-14       Impact factor: 8.192

9.  Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.

Authors:  Nicole Comtesse; Andreas Keller; Isabel Diesinger; Christine Bauer; Klaus Kayser; Hanno Huwer; Hans-Peter Lenhof; Eckart Meese
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

Review 10.  HIF-1 and tumour radiosensitivity.

Authors:  B J Moeller; M W Dewhirst
Journal:  Br J Cancer       Date:  2006-05-30       Impact factor: 7.640

View more
  50 in total

Review 1.  Role of translation initiation factor 4G in lifespan regulation and age-related health.

Authors:  Amber Howard; Aric N Rogers
Journal:  Ageing Res Rev       Date:  2014-01-03       Impact factor: 10.895

Review 2.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

Review 3.  Cross-talk between protein synthesis, energy metabolism and autophagy in cancer.

Authors:  Lisa M Lindqvist; Kristofferson Tandoc; Ivan Topisirovic; Luc Furic
Journal:  Curr Opin Genet Dev       Date:  2017-11-25       Impact factor: 5.578

4.  Role of the RNA-binding protein La in cancer pathobiology.

Authors:  Gunhild Sommer; Tilman Heise
Journal:  RNA Biol       Date:  2020-07-20       Impact factor: 4.652

5.  DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

Authors:  Libero Santarpia; Takayuki Iwamoto; Angelo Di Leo; Naoki Hayashi; Giulia Bottai; Martha Stampfer; Fabrice André; Nicholas C Turner; W Fraser Symmans; Gabriel N Hortobágyi; Lajos Pusztai; Giampaolo Bianchini
Journal:  Oncologist       Date:  2013-09-26

6.  Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells.

Authors:  Lindsey Decarlo; Celine Mestel; Mary-Helen Barcellos-Hoff; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2015-05-18       Impact factor: 4.272

7.  LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1.

Authors:  Sai Hu; Dafei Xie; Pingkun Zhou; Xiaodan Liu; Xiaoyao Yin; Bo Huang; Hua Guan
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

8.  Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.

Authors:  Fernanda Musa; Amandine Alard; Gizelka David-West; John P Curtin; Stephanie V Blank; Robert J Schneider
Journal:  Mol Cancer Ther       Date:  2016-05-16       Impact factor: 6.261

9.  SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.

Authors:  Yongmei Feng; Anthony B Pinkerton; Laura Hulea; Tongwu Zhang; Michael A Davies; Stefan Grotegut; Yann Cheli; Hongwei Yin; Eric Lau; Hyungsoo Kim; Surya K De; Elisa Barile; Maurizio Pellecchia; Marcus Bosenberg; Jian-Liang Li; Brian James; Christian A Hassig; Kevin M Brown; Ivan Topisirovic; Ze'ev A Ronai
Journal:  Cancer Res       Date:  2015-11-24       Impact factor: 12.701

Review 10.  New frontiers in translational control of the cancer genome.

Authors:  Morgan L Truitt; Davide Ruggero
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.